PLoS Neglected Tropical Diseases (Jun 2014)

Regulation of Schistosoma mansoni development and reproduction by the mitogen-activated protein kinase signaling pathway.

  • Luiza Freire de Andrade,
  • Marina de Moraes Mourão,
  • Juliana Assis Geraldo,
  • Fernanda Sales Coelho,
  • Larissa Lopes Silva,
  • Renata Heisler Neves,
  • Angela Volpini,
  • José Roberto Machado-Silva,
  • Neusa Araujo,
  • Rafael Nacif-Pimenta,
  • Conor R Caffrey,
  • Guilherme Oliveira

DOI
https://doi.org/10.1371/journal.pntd.0002949
Journal volume & issue
Vol. 8, no. 6
p. e2949

Abstract

Read online

BACKGROUND:Protein kinases are proven targets for drug development with an increasing number of eukaryotic Protein Kinase (ePK) inhibitors now approved as drugs. Mitogen-activated protein kinase (MAPK) family members connect cell-surface receptors to regulatory targets within cells and influence a number of tissue-specific biological activities such as cell proliferation, differentiation and survival. However, the contributions of members of the MAPK pathway to schistosome development and survival are unclear. METHODOLOGY/PRINCIPAL FINDINGS:We employed RNA interference (RNAi) to elucidate the functional roles of five S. mansoni genes (SmCaMK2, SmJNK, SmERK1, SmERK2 and SmRas) involved in MAPK signaling pathway. Mice were injected with post-infective larvae (schistosomula) subsequent to RNAi and the development of adult worms observed. The data demonstrate that SmJNK participates in parasite maturation and survival of the parasites, whereas SmERK are involved in egg production as infected mice had significantly lower egg burdens with female worms presenting underdeveloped ovaries. Furthermore, it was shown that the c-fos transcription factor was overexpressed in parasites submitted to RNAi of SmERK1, SmJNK and SmCaMK2 indicating its putative involvement in gene regulation in this parasite's MAPK signaling cascade. CONCLUSIONS:We conclude that MAPKs proteins play important roles in the parasite in vivo survival, being essential for normal development and successful survival and reproduction of the schistosome parasite. Moreover SmERK and SmJNK are potential targets for drug development.